Почетна › Немалоклетни карцином плућа › Ilinois › Evanston
Kliničke studije za Немалоклетни карцином плућа u gradu Evanston, IL
Jedna studija za Немалоклетни карцином плућа traži učesnike na lokaciji u gradu Evanston ili u blizini. Otvorite je da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Тражи се учесникФаза 3
- Illinois Cancer Specialists, Niles · 6 ми удаљено
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Тражи се учесникФаза 3
- Advocate Lutheran General Hospital, Park Ridge · 8 ми удаљено
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Тражи се учесникФаза 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 ми удаљено
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Тражи се учесникФаза 3
- NorthShore University HealthSystem-Evanston Hospital, Evanston
- NorthShore University HealthSystem-Glenbrook Hospital, Glenview · 5 ми удаљено
- Advocate Lutheran General Hospital, Park Ridge · 8 ми удаљено
- и још 1
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Тражи се учесникФаза 3
- Orchard Healthcare Research Inc. ( Site 0115), Skokie · 2 ми удаљено
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Тражи се учесникФаза 3
- North Shore University Health System ( Site 4014), Evanston
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Тражи се учесникФаза 3
- Research Site, Niles · 6 ми удаљено
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Тражи се учесникФаза 3
- Endeavor Health, Evanston
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Тражи се учесникОпсервациона студија
- Advocate Lutheran General Hospital, Park Ridge · 8 ми удаљено
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Тражи се учесникФаза 2/3
- USOR - Illinois Cancer Specialists - Niles, Niles · 6 ми удаљено
- Advocate Medical Group Oncology, Park Ridge · 8 ми удаљено
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Тражи се учесникФаза 2
- Illinois Cancer Specialists /ID# 274678, Niles · 6 ми удаљено
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Тражи се учесникФаза 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 ми удаљено
- Advocate Lutheran General Hospital, Park Ridge · 8 ми удаљено
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Тражи се учесникФаза 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 ми удаљено
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Тражи се учесникФаза 2/3
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 ми удаљено
- Advocate Lutheran General Hospital, Park Ridge · 8 ми удаљено
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Тражи се учесникФаза 3
- Illinois Cancer Specialists, Niles · 6 ми удаљено
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Тражи се учесникФаза 3
- Clinical Study Site, Evanston
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
Тражи се учесникОпсервациона студија
- Orchard Healthcare Research Inc., Skokie · 2 ми удаљено
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Тражи се учесникФаза 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 ми удаљено
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Тражи се учесникФаза 2
- Advocate Aurora Health, Park Ridge · 8 ми удаљено
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Тражи се учесникФаза 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 ми удаљено
- Advocate Lutheran General Hospital, Park Ridge · 8 ми удаљено
GEMINI-NSCLC: NSCLC Biomarker Study
Тражи се учесникОпсервациона студија
- Northwestern University, Evanston
Studije za Немалоклетни карцином плућа u drugim gradovima
- Houston, TX143 студија
- New York City, NY123 студија
- Arlington, VA111 студија
- Nashville, TN97 студија
- Los Angeles, CA92 студија
- Boston, MA87 студија
- St. Louis, MO68 студија
- Baltimore, MD60 студија
- San Antonio, TX60 студија
- Chicago, IL59 студија
- Columbus, OH57 студија
- Seattle, WA55 студија
Ostale studije u gradu Evanston
- Рак плућа19 студија
- Рак дојке13 студија
- Akutna mijeloidna leukemija11 студија
- Рак простате10 студија
- Гојазност10 студија
- Колоректални карцином10 студија
- Рак (све врсте)9 студија
- Ulcerativni kolitis9 студија
- Гојазност9 студија
- Кронова болест9 студија
- Атријална фибрилација8 студија
- Меланом8 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.